Synthesis and antiproliferative evaluation of oxime, methyloxime, and amide-containing quinazolinones
作者:Ken-Ming Chang、Li-Chai Chen、Cherng-Chyi Tzeng、Yao-Hua Lu、I-Li Chen、Shin-Hun Juang、Tai-Chi Wang
DOI:10.1002/jccs.201700463
日期:2018.9
Certain oxime, methyloxime, and amide‐containing quinazolinone derivatives were synthesized and evaluated in vitro for their antiproliferative activities against a panel of human cancer cell lines including nasopharyngeal carcinoma (NPC‐TW01), lung carcinoma (NCI‐H226), and leukemia (Jurkat). Quinazolinone 2 was inactive against all three cell lines tested, while quinazolinone 4 was weakly active against
合成了某些肟,甲基肟和含酰胺的喹唑啉酮衍生物,并在体外评估了它们对一系列人类癌细胞系(包括鼻咽癌(NPC-TW01),肺癌(NCI-H226)和白血病(Jurkat))的抗增殖活性)。喹唑啉酮2对所测试的所有三种细胞系均无活性,而喹唑啉酮4对Jurkat和H226癌细胞均具有弱活性,IC 50值分别为6.55和12.27μM,表明肟衍生物4比其酮前体2更有利。。我们的结果还表明,喹唑啉酮8g及其对应的联苯8f对所有测试的三种癌细胞系显示出比阳性对照甲氨蝶呤更有效的抗增殖活性。在这些喹唑啉酮衍生物中,8g对NPC-TW01的活性最高,IC 50值为4.78μM 。对NPC-TW01细胞周期分布的进一步研究表明,化合物8g以时间和浓度依赖的方式诱导细胞在G1 / G0期停滞。此外,在用8g处理72小时的NPC-TW01细胞中,发现了一个特征性的二倍体DNA含量峰(sub-G1)从1%增加到4%